| Phases | Total Enrollment |
|---|---|
| PHASE3 | 529388 |
| PHASE2 | 169108 |
| PHASE1 | 68180 |
Unleashing insights
In the year 2024, the landscape of clinical trials saw a significant enrollment trend across different phases. Phase III trials led the pack with a staggering 529,388 participants, showcasing the highest level of engagement and interest. Following closely behind, Phase II trials attracted 169,108 participants, while Phase I trials had 68,180 participants. This data highlights the progression of research and development efforts, with Phase III trials taking the lead in advancing potential treatments and therapies. The numbers speak volumes about the evolving dynamics of clinical research, with each phase playing a crucial role in the journey towards groundbreaking medical advancements.
Trend in Number of Phase III Trials Initiated from 2021 to 2023
Trend of Clinical Trials Over the Last 10 Years
HbA1c Improvement Observed with BASAGLAR in Type 2 Diabetes Patients
Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years
Top Pharmaceutical Companies by Number of Trials Published in the Last 5 Years
Enrollment trend in studies over the years
Comparison of Clinical Trials in Canada vs United States Over the Years
Count of Oncology Trials Starting in the Next 3 Months
Trend in Clinical Trials Initiated in Singapore Over the Last Three Years
Trend in Clinical Trials Initiated in the US Over the Last Three Years
Top 5 Most Common Biospecimen Retention Types in Clinical Trials
Trend of Clinical Trials Start Dates Over Time